Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Critique of an economic evaluation using the drummond checklist

This is a preview of subscription content, log in to check access.


  1. 1

    Sladkevicius E, Pollitt RJ, Mgadmi A, et al. Cost effectiveness of establishing a neonatal screening programme for phenylketonuria in Libya. Appl Health Econ Health Policy 2010; 8(6): 407–20

  2. 2

    Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996

  3. 3

    Drummond M, O’Brien B, Stoddart G, et al. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 1987

  4. 4

    The National Society for Phenylketonuria (NSPKU). Management of PKU: a consensus document for the diagnosis and management of children, adolescents and adults with phenylketonuria. London: NSPKU, 2004 [online]. Available from URL: [Accessed 2009 Jun 17]

  5. 5

    Liew D, McNeil J, Peeters A, et al. Epidemiological modelling (including economic modelling) and its role in preventive drug therapy. Med J Aust 2002; 177: 364–7

Download references


No sources of funding were used to prepare this editorial. The author has no conflicts of interest that are directly relevant to the content of this editorial.

Author information

Correspondence to Christopher M. Doran.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Doran, C.M. Critique of an economic evaluation using the drummond checklist. Appl Health Econ Health Policy 8, 357–359 (2010).

Download citation